(Submitted for publication July 14, 1960 ; accepted November 3, 1960) Serum lipid and lipoprotein alterations in nephrosis were discussed in detail in a previous report (1) . It was found that there were qualitative as well as quantitative differences in lipoproteins from one patient to another. Despite the differences in lipoprotein pattern, concentrations of serum cholesterol and phospholipids were related inversely to concentrations of serum albumin in a fairly regular manner. Triglycerides were consistently increased only when serum albumin fell below levels of about 1 g per 100 ml. These and other (2) observations suggest that hyperlipoproteinemia in nephrosis may be at least in part a result of hypoalbuminemia.
In order to study the effects on serum lipoproteins of altering the level of serum albumin without altering the disease, repeated infusions of serum albumin were administered to patients with nephrosis. Serum lipids and lipoproteins decreased as a result of the infusions. The decreases often were selective, involving principally the particular fractions which were most excessive at the beginning of the infusions. Changes in lipids and lipoproteins during infusions of dextran, and during steroid-induced remissions of the disease, were studied in several patients for comparison with the albumin results.
METHODS
Patients. The subjects were 9 patients with nephrosis (nephrotic syndrome) of unknown etiology. Age of the patients ranged from 5 to 46 years. Edema was present in all but one patient and proteinuria (4 to 15 g per day) was present in all cases prior to the initial course of infusions. A majority of the subjects was hospitalized, fed a low sodium diet, and studied for periods of several weeks before infusions were started. Body weight and levels of serum albumin, serum lipids, and urine protein were reasonably steady, except in Patient R.B., in whom steroid therapy had recently been discontinued, and in one additional patient who was excluded as noted later. Diet, schedule of activities, and other conditions were continued without change throughout the experimental periods. Quantity of food consumed was not rigidly controlled but did not change appreciably.
Albumin infusions. The courses of albumin with one exception consisted of a total of 175 to 1,075 g, given over periods of 7 to 26 days, in quantities of 25 or 50 g per day with a few exceptions which are noted. The albumin preparation was salt-poor Cohn fraction V in 25 per cent solution, supplied by the American National Red Cross. Each infusion was administered intravenously over a period of 1 to 2 hours, starting about 7:30 a.m., after first obtaining blood specimens for analysis if desired. Because of the rapid loss of albumin in the case of W.T., a final infusion of 90 g was given slowly over a 10 hour period.
Dextran infusions. One patient (F.G.) who had previously received albumin, was given 3 daily infusions of dextran in isotonic sodium chloride solution, and another patient (F.N.), a 30 year old male, was given 4 daily infusions of dextran in water. A third patient who received dextran, with results resembling those in F.G., was excluded because of a rapid increase in lipids just before the infusions were started. Each infusion, consisting of 30 g of dextran (average mole weight 75,000) in 6 per cent solution, was administered intravenously over a period of 6 to 8 hours.
Blood specimens and analytic procedures. Blood specimens for analysis were obtained about 7:30 a.m., after an overnight fast. Specimens during and at the end of the infusion periods were thereby taken almost 24 hours after the end of the most recent infusion. Shorter periods of time elapsed after the long albumin infusion in W.T. and the dextran infusions. Urine was collected continuously in 24-hour pools, starting at 7 a.m. For urine protein determinations, the infusion period was considered to extend to 7 a.m. of the day following the final infusion.
Many of the methods have been described in detail previously (1) . Total lipids were determined on chloroform-methanol extracts of serum by the method of Bragdon (3) . Determinations of total and free cholesterol were made by the Schoenheimer-Sperry procedure (4). Lipid phosphorus was determined by the method of Stewart and Hendry (5) and multiplied by a factor of 25 to obtain values for phospholipids. Triglycerides were calculated by difference (3), and therefore are possibly less accurate than the other lipids, particularly when triglycerides were relatively low. A modification of the dye interaction method of Rutstein, T Infusions were omitted on certain days (see Figures 1 and 4 ).
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Ingenito and Reynolds (6) was employed for serum albumin analysis, and urine protein was determined by a biuret method (7) . Lipoprotein fractions of serum were isolated by preparative ultracentrifugation after successive adjustments of serum density (1) , and analyzed by the methods described above. Free fatty acids were determined by the method of Gordon and Cherkes (8) .
Determinations of serum dextran were made as described by Semple (9) . Changes in plasma volume were calcu- Optical density read at 660 mtt in a Coleman Jr. spectrophotometer was taken as a measure of serum lactescence.
RESULTS

Effects of albumin infusions
Data on the albumin infusions and some of their effects are summarized in Table I . In Group I are courses in patients with clear serum and near normal triglycerides, while in Groups 2A and 2B are courses in patients with high levels of triglycerides as well as total cholesterol and phospholipids. Results of courses in Group 2A are possibly less significant than the others for reasons noted elsewhere.
Serum albumin concentration gradually increased in all patients but one (W.T.), and finally was increased briefly in this case by a large infusion. Proteinuria increased greatly. The maximal levels of proteinuria sometimes were approximately equal to the daily quantities of albumin infused. However, the excess protein in the urine (above the control level), during the infusion period and in the postinfusion period to the point of returning to the control level, was always less than the total quantity of albumin infused. Serum albumin concentration and proteinuria usually returned approximately to preinfusion levels within about a week after the infusions had been discontinued. An exception was the case of M.C. in whom proteinuria increased early in the infusion periods, but then decreased, and fell below control levels after the completion of each of two courses. It is evident that a partial remission of the disease occurred during the administration of albumin in this patient.
Diuresis accompanied the albumin infusions. The decrease in body weight and the increase in serum albumin usually progressed simultaneously. Complete loss of edema occurred in cases in which serum albumin levels were maintained above approximately 2 g per 100 ml. No adverse effects could be attributed to the albumin. Changes in serum electrolytes were in the direction of normal. Serum creatinine did not change appreciably. Hypertension or evidence of cardiac failure was not observed. In some cases, there was a striking increase in energy and feeling of wellbeing. However, the relief of symptoms usually did not last long.
The albumin infusions undoubtedly increased plasma volume and caused at least transitory dilution of serum lipids. Dilution also followed removal of blood for analysis. Plasma Table IV .
Absence of any appreciable increase in FFA throughout the day of an infusion in the third patient who received dextran (course not shown), and on successive days of infusions in F.N. (Figure 7 ), suggests that dextran had little if any lipoprotein lipase activity. Dextran caused no complications except for oliguria following the infusions in the third patient. Proteinuria increased significantly during two courses of dextran, in accord with previous observations (13) . (14) , malnutrition (15) , kwashiorkor (16) , or the hypercatabolic type of idiopathic hypoalbuminemia (17) in which low levels of serum albumin occur. Possibly this is because of associated nutritional or metabolic disturbances in these diseases when albumin is very low. In the ananabolic type of idiopathic hypoalbuminemia, serum cholesterol is consistently increased and decreases when albumin is infused (17) , but the degree and type of lipid alterations and also of edema resemble those seen in nephrosis with higher levels of serum albumin.
In the present study. albumin infusions in patients with nephrosis caused serum lipids and lipoproteins to decrease. Decreases in individual Soothill and Kark (21) , and was attributed to a decrease in hepatic synthesis of cholesterol occurring in connection with a presumed decrease in albumin synthesis. Allen (22) noted that lipids in nephrotic rats were changed toward normal by injections of various macromolecular substances in addition to albumin. Dextran had previously been observed to decrease serum cholesterol in nephrotic patients (23) and animals (24) and also in normal animals (25) . Albumin synthesis appears to be decreased by dextran (26, 27) . There is no assurance that albumin and dextran act in the same manner. However, the observation that dissimilar substances of large molecular size share the lipidreducing effect, suggests that the reduction may be mediated through changes in colloidal osmotic pressure or volume of the plasma.
The effects of albumin infusions on serum albumin concentration, proteinuria and edema were similar to those generally noted by previous investigators (28) (29) (30) (31) (32) 
